Published in Nebr Med J on September 01, 1991
The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med (1981) 1.45
Erythropoietic protoporphyria: the literature's confused counsel. J Am Acad Dermatol (1995) 1.39
Familial pancreatic cancer: a review. Semin Oncol (1996) 1.30
Tumour spectrum in the FAMMM syndrome. Br J Cancer (1981) 1.24
Systemic cancer and the FAMMM syndrome. Br J Cancer (1990) 1.12
Hereditary cancer in adults. Cancer Detect Prev (1995) 1.11
Familial atypical multiple mole melanoma (FAMMM) syndrome: genetic heterogeneity and malignant melanoma. Br J Cancer (1980) 0.99
Protection against long ultraviolet radiation: topical browning agents and a new outlook. Dermatologica (1987) 0.98
Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas (1991) 0.96
Muir-Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome. Br J Dermatol (1985) 0.96
Erythropoietic defects in protoporphyria: a study of factors involved in labelling of porphyrins and bile pigments from ALA- 3 H and glycine- 14 C. J Lab Clin Med (1971) 0.95
Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis. J Med Genet (1983) 0.93
Onychomycosis caused by Trichosporon beigelii in the United States. J Am Acad Dermatol (1984) 0.92
Erythropoietic protoporphyria. II. Histological and histochemical studies of cutaneous lesions. Arch Dermatol (1965) 0.89
The quantitative enzymic determination of animal liver glycogen. Anal Biochem (1966) 0.89
Sunlight protection in normal skin. By absorptive filter chemically induced in stratum corneum. Arch Dermatol (1966) 0.88
A review of hereditary malignant melanoma including biomarkers in familial atypical multiple mole melanoma syndrome. Cancer Genet Cytogenet (1983) 0.88
The Muir-Torre syndrome in kindreds with hereditary nonpolyposis colorectal cancer (Lynch syndrome): A classic obligation in preventive medicine. J Am Acad Dermatol (1999) 0.87
Phenotypic variation in the familial atypical multiple mole-melanoma syndrome (FAMMM). J Med Genet (1983) 0.86
Subcorneal pustular dermatosis. An immunoelectrophoretic study. Acta Derm Venereol (1965) 0.85
Abnormalities of T-cell subsets in Behçet's syndrome. Arch Dermatol (1983) 0.85
Topical glucocorticoids. How they are used and misused. Postgrad Med (1986) 0.85
Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families. Gastroenterology (2000) 0.84
Variable gastrointestinal and urologic cancers in a Lynch syndrome II kindred. Dis Colon Rectum (1991) 0.83
The role of the skin in carbohydrate metabolism. Adv Metab Disord (1972) 0.83
Cutaneous carbohydrate studies. IV. The skin glucose content of fasting diabetics with and without infection. J Invest Dermatol (1966) 0.82
Leprosy. IV. The quantitation of immune globulins (IgG, IgA, and IgM) in leprosy sera. Int J Lepr Other Mycobact Dis (1968) 0.82
Cancer genetics in the new era of molecular biology. Ann N Y Acad Sci (1997) 0.82
Learning style and academic performance within a group of sophomore medical students. Acad Med (1992) 0.81
Base-catalyzed isomerization of glucose and its effect on glucose oxidase analysis. Anal Biochem (1965) 0.81
Dermatitis herpetiformis and herpes gestationis. Analysis of γA and γM serum proteins by immunoelectrophoresis. J Invest Dermatol (1966) 0.80
Family history of cancer. Ann N Y Acad Sci (1995) 0.80
Muir-Torre syndrome and defective DNA mismatch repair genes. J Am Acad Dermatol (1996) 0.79
Palmar keratoses and internal malignancy. A negative study. Arch Dermatol (1968) 0.79
An unusual manifestation of the carcinoid syndrome. Report of a case. Arch Dermatol (1968) 0.79
Chromosome instability and the FAMMM syndrome. Cancer Genet Cytogenet (1993) 0.79
Photoprotection of patients sensitive to short and-or long ultraviolet light with dihydroxyacetone-naphthoquinone. Dermatologica (1974) 0.78
Enzymic analysis of rabbit skeletal muscle carbohydrate. Anal Biochem (1970) 0.78
Familial atypical multiple mole melanoma syndrome (FAMMM) Arch Dermatol (1983) 0.78
Antigenic relationships between lens, epidermis and other bovine tissues. Exp Eye Res (1971) 0.78
National Institutes of Health consensus report on precursors to malignant melanoma. A difference in opinion. JAMA (1984) 0.77
Erythropoietic protoporphyria. III. Photohemolysis. Arch Dermatol (1966) 0.77
Clinical results using informatics to evaluate hereditary cancer risk. Proc Annu Symp Comput Appl Med Care (1995) 0.77
Xeroderma pigmentosum. Complementation group C and malignant melanoma. Arch Dermatol (1984) 0.77
Erythropoietic protoporphyria. IV. Protection from sunlight. Br Med J (1970) 0.77
Eosinophilic cellulitis (Wells' syndrome) Arch Dermatol (1985) 0.77
Photosensitivity of the American Indian: terminology and historical aspects. J Am Acad Dermatol (1998) 0.77
Protection against long ultraviolet and/or visible light with topical dihydroxyacetone. Implications for the mechanism of action of the sunscreen combination, dihydroxyacetone/naphthoquinone. Dermatologica (1975) 0.76
Leprosy. II. IgA and IgM immunoproteins in leprosy sera. Int J Lepr Other Mycobact Dis (1970) 0.76
Hereditary malignant melanoma: a unifying etiologic hypothesis. Cancer Genet Cytogenet (1986) 0.76
Update on familial pancreatic cancer. Curr Gastroenterol Rep (2001) 0.76
Therapeutic potential of dihydroxyacetone. J Am Acad Dermatol (1993) 0.75
Creativity and peer review. Nat Biotechnol (1999) 0.75
Using data mining to characterize DNA mutations by patient clinical features. Proc AMIA Annu Fall Symp (1997) 0.75
The validation of medical histories in kindreds. Arch Dermatol (2001) 0.75
Liver transplantation in patients with erythropoietic protoporphyria. Gastroenterology (1990) 0.75
The factuality of health records. Arch Intern Med (2000) 0.75
The physician scientist, peer review, and creativity. J Am Acad Dermatol (1999) 0.75
Leser-Trelat sign in mother and daughter with breast cancer. J Med Genet (1982) 0.75
Prognosis of liver transplantation in patients with erythropoietic protoporphyria. Transplantation (1989) 0.75
Multiple interpretations of cancer risks from body mole counts in preventive care. Arch Dermatol (2001) 0.75
Leprosy. 3. A comparison of IgA and IgM immunoproteins of patients with pulmonary tuberculosis and leprosy. Int J Lepr Other Mycobact Dis (1970) 0.75
Overhaul of peer review at NIH. Lancet (1999) 0.75
Persistence of skin color and fluorescence after treatment with dihydroxyacetone. Dermatology (1994) 0.75
Hereditary photosensitivity of the American Indian. Int J Dermatol (1997) 0.75
Hereditary photosensitivity of the American Indian. Arch Dermatol (1990) 0.75
Dysplastic nevus syndrome. Ophthalmology (1986) 0.75
Hereditary malignant melanoma--conceptual differences. J Am Acad Dermatol (1985) 0.75
Tinea Pedis caused by Trichophyton violaceum. Am J Clin Pathol (1983) 0.75
Letter: Glycogen turnover in epidermis. Arch Dermatol (1973) 0.75
Statistical evaluation of oral Beta-carotene. J Invest Dermatol (1973) 0.75
Glycogen synthetase of human epidermis. J Invest Dermatol (1972) 0.75
Naming the melanoma-prone syndrome. Lancet (1981) 0.75
Melanoma and the atypical nevus. J Am Acad Dermatol (1987) 0.75
A contraindication for the use of charcoal in uremic patients. J Am Acad Dermatol (1981) 0.75
Protection against long ultraviolet light with dihydroxyacetone-naphthoquinone. Dermatologica (1973) 0.75
Protection of photosensitized rats against long ultraviolet radiation by topical application of compounds with structures similar to that of dihydroxyacetone. Dermatologica (1987) 0.75
Palmar keratoses and visceral cancer. A spurious relationship. Arch Dermatol (1972) 0.75
Letter: Nomenclature of erythropoietic protoporphyria. Arch Dermatol (1974) 0.75
A medical and genetic critique of the familial atypical multiple mole melanoma syndrome and the dysplastic nevus syndrome. Am J Dermatopathol (1985) 0.75
Leprosy. XII. T-cell subsets in lepromatous leprosy. Int J Dermatol (1982) 0.75
Keratoacanthomas associated with cervical squamous cell carcinoma. Arch Dermatol (1985) 0.75
The NIH Consensus Report on "Precursors to Malignant Melanoma". A different perspective. Am J Dermatopathol (1984) 0.75
Hereditary disorders--a dermatologist's role. J Am Acad Dermatol (1986) 0.75
The cutaneous evolution of nevi in a patient with familial, atypical, multiple-mole melanoma syndrome. Pediatr Dermatol (1985) 0.75
Current views on skin metabolism: the need for a broader outlook. Arch Dermatol (1972) 0.75
The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. Am J Ophthalmol (1984) 0.75
Cancer genetics: surveillance and control. Compr Ther (1987) 0.75
Influence of glycogen and oligoglucosides on glucose oxidase determination of skin glucose. Dermatologica (1972) 0.75
Glucose metabolism in psoriatic epidermis--localization of altered enzyme activities. Br J Dermatol (1973) 0.75
Dihydroxyacetone naphthoquinone sunscreen. JAMA (1972) 0.75
Letter: Nomenclature of erythropoietic protoporphyria. Arch Dermatol (1974) 0.75
Protection against light sensitivity with dihydroxyacetone-naphthoquinone. Int J Dermatol (1972) 0.75
Origin of plasma protoporphyrin in patients with erythropoietic protoporphyria. Arch Dermatol (1981) 0.75
Possible use of vitamins C and-or E in erythropoietic protoporphyria. JAMA (1973) 0.75
PFK: primary control in epidermal glycolysis. J Invest Dermatol (1973) 0.75
Inoculation technique for fungus cultures. Appl Microbiol (1972) 0.75
Cutaneous carbohydrate studies. II. The constancy of the glucose content of the skin of the back of normal persons. J Invest Dermatol (1965) 0.75
Immunotherapy in leprosy. JAMA (1982) 0.75
Lynch syndrome II and Lynch syndrome I. J Am Acad Dermatol (1985) 0.75